January 07, 2025 05:48 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
Japan approves home-made Covid-19 cure for emergency use

Japan approves home-made Covid-19 cure for emergency use

Nov 24, 2022, at 06:44 pm

Tokyo/UNI: The Japanese Health Ministry has authorised the island nation's first locally made COVID-19 oral treatment, Xocova, for emergency use.

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

May 08, 2021, at 11:57 pm

New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.

After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin

After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin

Dec 08, 2020, at 04:41 am

New Delhi/IBNS:  After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.